Thursday, October 29, 2015

Isis Pharmaceuticals Will Review ISIS-TTR Rx Data and Provide Phase 3 Development Plan Update

Isis Pharmaceuticals to Host Webcast to Review ISIS-TTR Rx Data
This data was Presented at 1st European Congress of Hereditary ATTR Amyloidosis. The company will also Provide Phase 3 Development Plan Update
The Webcast is scheduled on Tuesday, November 3 at 8:00 a.m. Eastern Time and has been added to the Binary Event Logger Calendar below.
Here's the release.

No comments:

Post a Comment